Kerstin Hartwig

Title: Kerstin Hartwig: Innovator in Pharmaceutical Composition

Introduction

Kerstin Hartwig is a notable inventor based in Austria, recognized for her contributions to the field of pharmaceuticals. She has developed innovative solutions aimed at improving patient care and treatment outcomes. Her work primarily focuses on compositions that enhance the administration of medications.

Latest Patents

Kerstin Hartwig holds a patent for an invention titled "Aqueous Composition Of Apomorphine For Subcutaneous Administration." This invention relates to an aqueous composition that includes apomorphine or a pharmaceutically acceptable salt or solvate thereof, reduced glutathione (GSH), and ascorbic acid or a pharmaceutically acceptable salt or derivative thereof. The composition is designed to have a pH of about 3 to about 7.4. It exhibits superior tolerability and an improved side effect profile, particularly reducing the occurrence of skin nodule formation and panniculitis when administered subcutaneously. This composition is particularly relevant for the treatment of Parkinson's disease.

Career Highlights

Kerstin Hartwig is currently associated with Ever Neuro Pharma GmbH, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to developing effective and safe treatment options for patients.

Collaborations

Kerstin collaborates with esteemed colleagues, including Sabine Schmidt and Heinz Schnait, who contribute to her research and development efforts. Their combined expertise enhances the quality and impact of their work in the pharmaceutical industry.

Conclusion

Kerstin Hartwig's contributions to pharmaceutical compositions demonstrate her dedication to improving medical treatments. Her innovative work, particularly in the formulation of apomorphine, highlights the importance of research in enhancing patient care.